Article

Q&A session with Dr. Michael R. Samardzija of dentons US LLP: On the Question: What are the prospects and impediments for biosimilar products in the United States?

Biotechnology Law Report
DOI: 10.1089/blr.2014.9968
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Holman, C. M., & Samardzija, M. R. (2014, December 1). Q&A session with Dr. Michael R. Samardzija of dentons US LLP: On the Question: What are the prospects and impediments for biosimilar products in the United States? Biotechnology Law Report. Mary Ann Liebert Inc. https://doi.org/10.1089/blr.2014.9968

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free